170 related articles for article (PubMed ID: 19728195)
1. Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer.
Chopra S; Foltz WD; Milosevic MF; Toi A; Bristow RG; Ménard C; Haider MA
Int J Radiat Biol; 2009 Sep; 85(9):805-13. PubMed ID: 19728195
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations.
Hoskin PJ; Carnell DM; Taylor NJ; Smith RE; Stirling JJ; Daley FM; Saunders MI; Bentzen SM; Collins DJ; d'Arcy JA; Padhani AP
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1065-71. PubMed ID: 17637389
[TBL] [Abstract][Full Text] [Related]
4. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.
Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Hareyama M; Satoh M
Strahlenther Onkol; 2006 Sep; 182(9):511-7. PubMed ID: 16944372
[TBL] [Abstract][Full Text] [Related]
5. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
[TBL] [Abstract][Full Text] [Related]
6. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer.
Parker C; Milosevic M; Toi A; Sweet J; Panzarella T; Bristow R; Catton C; Catton P; Crook J; Gospodarowicz M; McLean M; Warde P; Hill RP
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):750-7. PubMed ID: 14967430
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive monitoring of renal oxygenation using BOLD-MRI: a reproducibility study.
Simon-Zoula SC; Hofmann L; Giger A; Vogt B; Vock P; Frey FJ; Boesch C
NMR Biomed; 2006 Feb; 19(1):84-9. PubMed ID: 16411163
[TBL] [Abstract][Full Text] [Related]
8. BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease.
Chrysochou C; Mendichovszky IA; Buckley DL; Cheung CM; Jackson A; Kalra PA
Nephrol Dial Transplant; 2012 Mar; 27(3):1013-9. PubMed ID: 21856759
[TBL] [Abstract][Full Text] [Related]
9. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis.
Han F; Xiao W; Xu Y; Wu J; Wang Q; Wang H; Zhang M; Chen J
Nephrol Dial Transplant; 2008 Aug; 23(8):2666-72. PubMed ID: 18308769
[TBL] [Abstract][Full Text] [Related]
10. Blood Oxygenation Level-dependent Magnetic Resonance Imaging of Breast Cancer: Correlation with Carbonic Anhydrase IX and Vascular Endothelial Growth Factor.
Wang Y; Liu M; Jin ML
Chin Med J (Engl); 2017 5th Jan 2017; 130(1):71-76. PubMed ID: 28051026
[TBL] [Abstract][Full Text] [Related]
11. A preliminary study of blood-oxygen-level-dependent MRI in patients with chronic kidney disease.
Xin-Long P; Jing-Xia X; Jian-Yu L; Song W; Xin-Kui T
Magn Reson Imaging; 2012 Apr; 30(3):330-5. PubMed ID: 22244540
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
[TBL] [Abstract][Full Text] [Related]
13. Transperineal prostate biopsy under magnetic resonance image guidance: a needle placement accuracy study.
Blumenfeld P; Hata N; DiMaio S; Zou K; Haker S; Fichtinger G; Tempany CM
J Magn Reson Imaging; 2007 Sep; 26(3):688-94. PubMed ID: 17729363
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
Franiel T; Lüdemann L; Taupitz M; Rost J; Asbach P; Beyersdorff D
Rofo; 2009 Jun; 181(6):536-42. PubMed ID: 19353483
[TBL] [Abstract][Full Text] [Related]
15. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
Gibbs P; Liney GP; Pickles MD; Zelhof B; Rodrigues G; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841
[TBL] [Abstract][Full Text] [Related]
16. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
Scheidler J; Vogel M; Gross P; Heuck A
Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
[TBL] [Abstract][Full Text] [Related]
17. Functional magnetic resonance imaging in prostate cancer.
Seitz M; Shukla-Dave A; Bjartell A; Touijer K; Sciarra A; Bastian PJ; Stief C; Hricak H; Graser A
Eur Urol; 2009 Apr; 55(4):801-14. PubMed ID: 19185981
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
Puech P; Potiron E; Lemaitre L; Leroy X; Haber GP; Crouzet S; Kamoi K; Villers A
Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of intrarenal oxygenation by blood oxygen level-dependent magnetic resonance imaging in living kidney donors and their recipients: preliminary results.
Malvezzi P; Bricault I; Terrier N; Bayle F
Transplant Proc; 2009 Mar; 41(2):641-4. PubMed ID: 19328943
[TBL] [Abstract][Full Text] [Related]
20. Computerized characterization of prostate cancer by fractal analysis in MR images.
Lv D; Guo X; Wang X; Zhang J; Fang J
J Magn Reson Imaging; 2009 Jul; 30(1):161-8. PubMed ID: 19557732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
